Nonadherence in Patients With Breast Cancer Receiving Oral Therapies
- 1 January 2010
- journal article
- review article
- Published by Oncology Nursing Society (ONS) in Clinical Journal of Oncology Nursing
- Vol. 14 (1), 41-7
- https://doi.org/10.1188/10.cjon.41-47
Abstract
Adherence is a potentially significant issue in oral therapy for breast cancer. Suboptimal adherence to medication regimens impacts clinical benefit and can result in treatment resistance, disease progression, and even death. Nonadherence is a greater issue with oral medications because the majority of responsibility shifts from healthcare professionals to the patient. Improving adherence to medication regimens can impact patients' likelihood of successful clinical outcomes. Many factors contribute to adherence behavior, such as complex dosing or administration requirements, cost, and a lack of understanding of the importance of adherence. Most of the factors are controlled by the patient, but nurses can play a significant role by monitoring patients, identifying potential barriers to adherence, and implementing intervention strategies. If barriers to adherence with oral therapies cannot be overcome, the use of IV therapies with equivalent efficacy and acceptable safety should be considered. Using IV medication, when available, can improve outcomes by ensuring that the patient receives the correct and optimal dose of medication at every cycle.Keywords
This publication has 38 references indexed in Scilit:
- Interventions for enhancing medication adherenceCochrane Database of Systematic Reviews, 2008
- Early discontinuation of tamoxifenCancer, 2007
- Intentional and non-intentional non-adherence to medication amongst breast cancer patientsEuropean Journal Of Cancer, 2006
- Effect of Personal and Cultural Beliefs on Medication Adherence in the ElderlyDrugs & Aging, 2006
- Adherence beliefs among breast cancer patients taking tamoxifenPatient Education and Counseling, 2005
- Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancerAnnals of Oncology, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Patient Beliefs and Tamoxifen Discontinuance in Older Women With Estrogen Receptor—Positive Breast CancerJournal of Clinical Oncology, 2004
- A systematic review of the associations between dose regimens and medication complianceClinical Therapeutics, 2001
- Adverse drug events as a cause of hospital admission in the elderlyInternal Medicine Journal, 2001